Indie Label Assoc. A2IM Calls For FCC Payola Probe
Last week A2IM (The American Association of Independent Music) which represents more than 100 indie labels sent the FCC a letter urging the commission to investigate radio to see if there’s a level playing field for indies vs. the majors. The letter is particularly poignant given yesterday’s court filings against radio group Entercom as part of NY Atty. General Eliot Spitzer widening payola investigation. Spitzer has also been very critical of the FCC’s lack of action. Some highlights from A2IM the letter:
"…One of the most serious allegations facing the broadcast industry is that radio stations engaged in business activities that made it virtually impossible for songs released by independent labels to be considered for airplay within existing formats. Independent music is booming…independent labels now make up over 27% of sales in the American music market (and about 80% of the music available to consumers—representing the broad cultural diversity of the musical landscape). Yet, somehow, music released by independents is virtually absent from the commercial airwaves…"
"…the New York AG has initiated action at the state level and has successfully garnered disclosure and settlements from two of the major recording companies so far. The associated fines are viewed by many in our sector as mere slaps on the wrists in comparison to the financial harm caused nationally…"
"It is absolutely vital that any full investigation addresses the issue of how to ensure that the vast diversity of American music has a fair opportunity to access the public airwaves."
Click below to read the full text of the letter.
I am writing today to express our enthusiastic reaction to news reports that the FCC is conducting a thorough investigation of alleged payola-like practices in the commercial radio industry. In particular, I want to offer our assistance in helping the Commission understand how these alleged practices have impacted the independent music industry.
One of the most serious allegations facing the broadcast industry is that radio stations engaged in business activities that made it virtually impossible for songs released by independent labels to be considered for airplay within existing formats. Independent music is booming—innovative programmers highlight songs released on independent labels on satellite radio, non-commercial stations and webcasts. Well over half of the releases cited in January’s Village Voice Critics Poll were released by independent labels. The marketplace is responding, as independent labels now make up over 27% of sales in the American music market (and about 80% of the music available to consumers—representing the broad cultural diversity of the musical landscape). Yet, somehow, music released by independents is virtually absent from the commercial airwaves.
While we are very concerned that many critical musical genres like jazz, classical, blues, folk and bluegrass have essentially disappeared from commercial radio, perhaps not coincidental with the outgrowth of radio consolidation, we are not asking for new formats to be created focusing solely on independent music. What we demand is a legitimate opportunity for our members’ music to appear on commercial radio playlists—an opportunity that we believe has been denied to our members due to these alleged practices.
As you are undoubtedly aware, the New York AG has initiated action at the state level and has successfully garnered disclosure and settlements from two of the major recording companies so far. The associated fines are viewed by many in our sector as mere slaps on the wrists in comparison to the financial harm caused nationally.
It is absolutely vital that any full investigation addresses the issue of how to ensure that the vast diversity of American music has a fair opportunity to access the public airwaves.
Sincerely,
Don Rose
Acting President
CC: A2IM Board of Directors:
Lesley Bleakley, Beggars Group
Peter Gordon, Thirsty Ear
Steve Gottlieb, TVT Records
Doug Keogh, Roadrunner Records
Glenn Morrow, Bar-None
Molly Neuman, Lookout Records
Thomas Silverman, Tommy Boy
Letter via Hits.
A meandering tale, or, why I love the BBC.
In the British folk music world, there is a long and sad tale involving a label which bought up many prominent 70s folk recordings, and has recently been issuing them on CD-R without paying the artists. Due to some quirk in British law, this is legal.
On a BBC discussion board, some fans of the cheated artists were pressing the BBC’s representatives — why are you playing these immoral CD-R reissues on your shows? Why don’t you support the artists by refusing to play them?
***** The BBC representative’s reply was: If we used any consideration other than musical quality in deciding what to air, action could be taken against us. *****
Now you might think that in this specific case, maybe the BBC should be allowed to boycott recordings which don’t pay royalties to artists. But in the broader case: the BBC is only allowed to consider musical quality in deciding what gets played. Wow.
Or, as I’ve phrased it for some time: there doesn’t appear to be many people left in America whose job description reads, “Responsible for selecting good music.”
I’ll get off my rant now.
The main fault with the letter is that it assumes critical praise is somehow related to commercial potential.
Let’s all return to planet Earth for a moment, shall we?
hair loss pills
hair loss pills
stop losing hair
stop losing hair
Discount Sildenafil
sildenafil
Discount Tadalafil tadalafil
Discount Levitra
cheap levitra
Discount Soma cheap
some, Generic soma
Discount Propecia
cheap propecia, Generic
Propecia
Discount Celebrex cheap
celebrex, Generic Celebrex
Discount Glucophage cheap
glucophage, Generic glucophage
Discount Norvasc cheap norvasc,
Generic Norvasc
Discount Zocor cheap zocor,
Generic Zocor
Discount Retin-A cheap
retin-a, Generic Retin-A
Discount Wellbutrin
cheap wellbutrin, Generic
Wellbutrin
Discount Alegra D cheap
allegra D, Generic Alegra D
Discount Claritin cheap
claritin, Generic Claritin
Discount Zantac cheap zantac,
Generic Zantac
Discount Cialis cheap cialis,
Generic Cialis
Discount Zoloft cheap zoloft,
Generic Zoloft
Discount Atenolol cheap atenolol, Generic Atenolol
Discount Ampicillin
cheap ampicilin, Generic
Ampicillin
Discount Avandia
cheap avandia, Generic Avandia
Discount Actos cheap actos, Generic Actos
Discount Augmentin
cheap augmentin, Generic Augmentin
Discount Diflucan cheap diflucan, Generic Diflucan
Discount Clomid cheap
clomid, Generic Clomid
Discount Evista cheap
evista, Generic Evista
Discount Imitrex
cheap imitrex, Generic
Imitrex
Discount Nexium
cheap nexium, Generic
Nexium
Discount Nolvadex
cheap nolvadex, Generic
Nolvadex
Discount Paxil
cheap paxil, Generic Paxil
Discount Prilosec
cheap prilosec, Generic
Prilosec
Discount Viagra cheap
viagra, Generic Viagra
Discount Xenical
cheap xenical, Generic
Xenical
Discount Zovirax
cheap zovirax, Generic
Zovirax
Discount Zyrtec cheap
zyrtec, Generic Zyrtec
Buy Prescription
drugs buy prescription drugs without prescription
Generic drugs Generic drugs
Prescription drugs Prescription drugs
Discount pharmacy Discount pharmacy
Discount Pharmacy discount pharmacy
best choice
Online Pharmacy cheap online pharmacy
store,
Discount Online Pharmacy at best prices.
Sildenafil Citrate
Sildenafil Citrate pills
Tadalafil – Tadalafil
pills and Generic Cialis – Generic Cialis pills
Vardenafil HCI (Generic
Levitra)
6-Tablet Trial Pack
Carisoprodol (Generic
Soma)
Finasteride (Generic
Propecia)
Atorvastatin (Generic
Lipitor)
Sibutramine (Generic
Meridia)
Celecoxib (Celebrex)
Metformin (Glucophage)
Amlodipine (Norvasc)
Simvastatin (Zocor)
Tretinoin (Generic
Retin-A)
Atomoxetine (Generic
Strattera)
Bupropion SR (Generic
Wellbutrin)
Eszopiclone (Generic
Lunesta)
Fexofenadine (Alegra
D)
Loratidine (Claritin)
Ranitidine (Zantac)
Regalis (Cialis)
Sertraline (Zoloft)